scholarly journals A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer

1995 ◽  
Vol 72 (5) ◽  
pp. 1256-1258 ◽  
Author(s):  
RV Iaffaioli ◽  
A Tortoriello ◽  
G Facchini ◽  
M Santangelo ◽  
G De Sena ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Line Treatment ◽  
Second Line

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study

2010 ◽  
Vol 30 (2) ◽  
pp. 681-687 ◽  
Author(s):  
Katalin Boér ◽  
István Láng ◽  
Antonio Llombart-Cussac ◽  
Inger Andreasson ◽  
Guillermo L. Vivanco ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Line Treatment ◽  
Second Line ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Randomized Phase Ii

scholarly journals Front-line treatment of advanced breast cancer with docetaxel and epirubicin: A multicenter phase II study

2000 ◽  
Vol 11 (10) ◽  
pp. 1249-1254 ◽  
Author(s):  
D. Mavroudis ◽  
A. Alexopoulos ◽  
N. Ziras ◽  
N. Malamos ◽  
C. Kouroussis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Line Treatment ◽  
Front Line ◽  
Multicenter Phase

scholarly journals A phase II trial with Docetaxel (Taxotere™) in second line treatment with chemotherapy for advanced breast cancer

1994 ◽  
Vol 5 (6) ◽  
pp. 527-532 ◽  
Author(s):  
W.W. ten Bokkel Huinink ◽  
A.M. Prove ◽  
M. Piccart ◽  
W. Steward ◽  
T. Tursz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Line Treatment ◽  
Second Line
Sign in / Sign up

Export Citation Format

Share Document